IDH1 and glioblastoma: Subtype-specific localization was most prominent in oligodendrogliomas, where 80.8% of IDH1/2-mutant/1p19q-co-deletion tumors originated in the frontal lobe compared to 32.1% of IDH1/2-wild-type GBM (Fig. S7).